| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 21.266 | 64.786 | 71.520 | 87.981 |
| Total Income - EUR | - | - | - | - | - | - | 21.266 | 64.787 | 75.314 | 106.761 |
| Total Expenses - EUR | - | - | - | - | - | - | 13.378 | 35.947 | 40.200 | 73.041 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 7.888 | 28.840 | 35.114 | 33.720 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 7.667 | 28.192 | 34.457 | 31.404 |
| Employees | - | - | - | - | - | - | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Sofcris Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 16.476 | 12.743 | 9.554 | 18.012 |
| Current Assets | - | - | - | - | - | - | 8.256 | 29.024 | 58.251 | 23.606 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 1.131 | 0 |
| Receivables | - | - | - | - | - | - | 5.442 | 5.370 | 47.179 | 19.002 |
| Cash | - | - | - | - | - | - | 2.814 | 23.655 | 9.941 | 4.604 |
| Shareholders Funds | - | - | - | - | - | - | 7.707 | 28.233 | 34.498 | 31.445 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 17.025 | 13.535 | 32.123 | 10.174 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 18.936 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sofcris Medical S.r.l.